acetylcysteine and Lymphoma, Large B-Cell, Diffuse

acetylcysteine has been researched along with Lymphoma, Large B-Cell, Diffuse in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chapuy, B; Chen, L; Chen, PH; Choi, DW; Danial, NN; Ficarro, SB; Lako, A; Lee, S; Marto, JA; Norberg, E; Rodig, S; Shin, D; Shipp, MA; Stanley, IA; Zhou, F	1
Bhaskar, AS; Deb, U; Kumar, O; Lakshmana Rao, PV	1
Hayashi, T; He, H; Ikejima, T; Liu, W; Onodera, S; Tashiro, S; Xu, Q; Yu, Y; Zang, L; Zheng, N	1
Schenkein, D	1

Reviews

1 review(s) available for acetylcysteine and Lymphoma, Large B-Cell, Diffuse

Article	Year
Proteasome inhibitors in the treatment of B-cell malignancies. Clinical lymphoma, 2002, Volume: 3, Issue:1 Topics: Acetylcysteine; Animals; Boronic Acids; Bortezomib; Cell Cycle Proteins; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Enzymes; Gene Expression Regulation; Hodgkin Disease; Humans; Leukemia, B-Cell; Leupeptins; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Mice; Multiple Myeloma; Neoplasm Proteins; NF-kappa B; Oncogene Proteins; Peptide Hydrolases; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Substrate Specificity; Transcription Factors; Treatment Outcome	2002

Article

Year

Proteasome inhibitors in the treatment of B-cell malignancies.

Clinical lymphoma, 2002, Volume: 3, Issue:1

Topics: Acetylcysteine; Animals; Boronic Acids; Bortezomib; Cell Cycle Proteins; Clinical Trials as Topic; Drug Screening Assays, Antitumor; Enzymes; Gene Expression Regulation; Hodgkin Disease; Humans; Leukemia, B-Cell; Leupeptins; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Mice; Multiple Myeloma; Neoplasm Proteins; NF-kappa B; Oncogene Proteins; Peptide Hydrolases; Protease Inhibitors; Proteasome Endopeptidase Complex; Pyrazines; Substrate Specificity; Transcription Factors; Treatment Outcome

2002

Other Studies

3 other study(ies) available for acetylcysteine and Lymphoma, Large B-Cell, Diffuse

Article	Year
Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets. Cell death and differentiation, 2017, Volume: 24, Issue:2 Topics: Acetylcysteine; Amino Acid Motifs; Anti-Bacterial Agents; Cell Survival; Electron Transport Chain Complex Proteins; Humans; Lymphoma, Large B-Cell, Diffuse; Mitochondria; Mitochondrial Proteins; Oxidative Phosphorylation; Peptide Elongation Factor G; Peptide Elongation Factor Tu; Reactive Oxygen Species; Receptors, Antigen, B-Cell; Ribosomal Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Tumor Cells, Cultured	2017
Abrin induced oxidative stress mediated DNA damage in human leukemic cells and its reversal by N-acetylcysteine. Toxicology in vitro : an international journal published in association with BIBRA, 2008, Volume: 22, Issue:8 Topics: Abrin; Acetylcysteine; Antioxidants; Comet Assay; DNA Damage; Free Radical Scavengers; Glutathione; Humans; Inhibitory Concentration 50; Lymphoma, Large B-Cell, Diffuse; Oxidative Stress; Ribosome Inactivating Proteins; Time Factors; U937 Cells	2008
Reactive oxygen species H2O2 and •OH, but not O2•(-) promote oridonin-induced phagocytosis of apoptotic cells by human histocytic lymphoma U937 cells. International immunopharmacology, 2013, Volume: 15, Issue:2 Topics: Acetylcysteine; Apoptosis; Autophagy; Diterpenes, Kaurane; Free Radical Scavengers; Humans; Hydrogen Peroxide; Hydroxyl Radical; Lymphoma, Large B-Cell, Diffuse; MAP Kinase Signaling System; Phagocytosis; Phosphatidylinositol 3-Kinases; Phospholipase C gamma; raf Kinases; ras Proteins; Reactive Oxygen Species; U937 Cells	2013